Zenith Healthcare

Zenith Healthcare Quick Ratio

Quick Ratio (Acid Test) of Zenith Healthcare (530665.BO) as of Oct 27, 2026.

Quick Ratio

0.00

YoY

-100.00%

Last updated:

Quick Ratio (Acid Test) of Zenith Healthcare is 2026 0.00 . Quick Ratio (Acid Test) of Zenith Healthcare was 2025 4.26 . It decreases by -100.00% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenith Healthcare Stock analysis

What does Zenith Healthcare do? Zenith Healthcare Ltd. manufactures pharmaceutical formulations including tablets, capsules, oral liquids, and injections for various therapeutic segments. The company sells products such as Roxythromycin Tablets, Ciprofloxacin Tablets, Azithromycine Dihydrate Suspension, Azithromycin Oral Suspension under antibiotics and anti-infective, Ranitidine Hydrochloride Tablets for gastrointestinal, Lisinopril Tablets for cardiovascular system, and Paracetamol and Aceclofenac Tablets for analgesic/anti-inflammatory categories. It also provides contract manufacturing services for all dosage forms. The company's primary customers are healthcare providers and pharmacies that purchase its branded pharmaceutical products. Zenith Healthcare targets therapeutic segments including antibiotics, gastrointestinal, cardiovascular, analgesic, and others as specified in its product portfolio. Its contract manufacturing services are offered to other pharmaceutical companies seeking production capabilities. Zenith Healthcare's revenue streams come from direct sales of its branded pharmaceutical products across multiple therapeutic segments and from contract manufacturing agreements. The company focuses on delivering products in key therapeutic areas such as antibiotics, gastrointestinal, cardiovascular, and analgesic markets where it has established product lines. Zenith Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenith Healthcare stock

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Zenith Healthcare since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Zenith Healthcare with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Zenith Healthcare

All Key Metrics — Zenith Healthcare